Companies / BOC Sciences / Lintuzumab
BOC Sciences

Lintuzumab | BOC Sciences

(0) Write Review

Lintuzumab is a humanized monoclonal antibody directed against CD33. Lintuzumab is developed for the treatment of acute myeloid leukemia.

Reviews

(0) | Be the first to review this product
No reviews yet

ABOUT THE COMPANY

BOC Sciences
BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.
Scientific Products
  • See More
    • Upcoming Virtual Events
    Upcoming Webinars